Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (451-460 of 621) with videos related to

Pageof 63
Sort By:
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Basic Research in Cardiology|December 22, 2019
Heart non-specific effector CD4<sup>+</sup> T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditisMartina Zarak-Crnkovic, Gabriela Kania, Agnieszka Jaźwa-Kusior, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Science Translational Medicine|October 1, 2020
Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosisDebomita Chakraborty, Honglin Zhu, Astrid Jüngel, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Annals of the Rheumatic Diseases|May 13, 2017
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosisChristian Beyer, Dörte Huscher, Andreas Ramming, et al.
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
Annals of the Rheumatic Diseases|October 27, 2017
The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosisChristina Bergmann, Amelie Brandt, Benita Merlevede, et al.
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Pageof 63

Showing results (451-460 of 621) with videos related to

Sort By:
Pageof 63
Annals of the Rheumatic Diseases|October 25, 2017
Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohortCarina Mihai, Milos Antic, Rucsandra Dobrota, et al.
Basic Research in Cardiology|December 22, 2019
Heart non-specific effector CD4<sup>+</sup> T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditisMartina Zarak-Crnkovic, Gabriela Kania, Agnieszka Jaźwa-Kusior, et al.
Rheumatology (Oxford, England)|March 29, 2022
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohortElisabetta Zanatta, Dörte Huscher, Augusta Ortolan, et al.
Science Translational Medicine|October 1, 2020
Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosisDebomita Chakraborty, Honglin Zhu, Astrid Jüngel, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Annals of the Rheumatic Diseases|May 13, 2017
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosisChristian Beyer, Dörte Huscher, Andreas Ramming, et al.
Arthritis Research & Therapy|December 11, 2014
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT studyScott H Visovatti, Oliver Distler, J Gerry Coghlan, et al.
Annals of the Rheumatic Diseases|October 27, 2017
The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosisChristina Bergmann, Amelie Brandt, Benita Merlevede, et al.
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
JAMA Dermatology|June 28, 2023
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR DatabaseAlain Lescoat, Suiyuan Huang, Patricia E Carreira, et al.
Pageof 63